Table 4.
Item-response probabilities for three PrEP training content recommendation profiles reported by healthcare providers (N = 359)
| Class prevalence | Class 1 | Class 2 | Class 3 |
|---|---|---|---|
| PrEP clinical implementation only | PrEP clinical implementation and PrEP background | PrEP clinical implementation and comprehensive sexual health background | |
| 23.65% | 43.75% | 32.60% | |
| Content recommendation | Item response probabilities | ||
| HIV background | 0.12 | 0.23 | 0.87 |
| Efficacy of PrEP | 0.44 | 0.91 | 1.00 |
| Risks/side effects of PrEP | 0.41 | 0.93 | 1.00 |
| Clinical trial evidence for PrEP | 0.43 | 0.81 | 0.95 |
| Biological mechanism of PrEP | 0.15 | 0.25 | 0.80 |
| Clinical protocol for initiating and monitoring patients on PrEP | 0.62 | 0.98 | 0.97 |
| How to take sexual history | 0.41 | 0.42 | 0.97 |
| How to talk about sex with sexual minority patients | 0.42 | 0.32 | 0.96 |
| Adherence and drug resistance | 0.31 | 0.57 | 0.95 |
| Clinical guidelines for determining patient eligibility for PrEP | 0.50 | 0.95 | 0.94 |